Published in Aliment Pharmacol Ther on June 15, 2004
Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis). Dig Dis Sci (2007) 1.39
Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91
Gastric carditis: Is it a histological response to high concentrations of luminal nitric oxide? World J Gastroenterol (2006) 0.75
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Safety of cold polypectomy for <10mm polyps at colonoscopy: a prospective multicenter study. Endoscopy (2011) 3.91
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79
Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology (1997) 2.47
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol (1993) 1.74
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Duodenal ulcer relapse after eradication of Helicobacter pylori. Lancet (1991) 1.64
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol (1999) 1.50
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther (2004) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol (1996) 1.44
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44
[Brain death and prolonged fetal survival]. Minerva Anestesiol (1992) 1.42
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42
Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralized facility testing. Eur J Gastroenterol Hepatol (2000) 1.41
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol (1997) 1.40
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series. Ital J Gastroenterol Hepatol (1998) 1.40
H2 antagonist and omeprazole nonresponders. Dig Dis Sci (1991) 1.39
[Who needs a gastroenterology pathologist?]. Pathologica (1996) 1.38
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 1.38
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
Lymphocytic gastritis: a positive relationship with celiac disease. J Pediatr (1994) 1.24
Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci (1999) 1.18
Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care (1995) 1.18
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology (1991) 1.17
Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol (1996) 1.15
A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res (2009) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol (1990) 1.10
The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut (1999) 1.10
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis (2005) 1.09
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 1.09
Gastric endocrine cells: types, function and growth. Regul Pept (2000) 1.09
Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol (1995) 1.08
Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia. J Pathol (1997) 1.08
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.08
Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med (1994) 1.07
Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Aliment Pharmacol Ther (2014) 1.06
Mean and median of pH values, characterizing average intragastric acidity. Am J Gastroenterol (1989) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04
Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion (1992) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
Helicobacter pylori infection and chronic gastritis: clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. J Pediatr Gastroenterol Nutr (1990) 1.03
Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflammatory reaction. Diabetes Care (2001) 1.02
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.02
Observer agreement on the grading of gastric atrophy. Histopathology (1999) 1.01
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol Suppl (1994) 1.01
Microsatellite instability in intestinal- and diffuse-type gastric carcinoma. J Pathol (1997) 1.00
Persistence of Helicobacter pylori VacA toxin and vacuolating potential in cultured gastric epithelial cells. Am J Physiol (1998) 0.99
Acid and gastric metaplasia in the duodenum. Gut (1994) 0.98
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.98
Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol (1994) 0.97
The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch (2001) 0.97
Letter: biological therapies are effective for prevention of post-operative Crohn's disease recurrence. Aliment Pharmacol Ther (2014) 0.96
Malignant tumors in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects. Anticancer Res (1994) 0.96
Gastric metaplasia and Helicobacter pylori infection. Gut (1995) 0.96
Endocrine tumors of the small and large intestine. Pathol Res Pract (1995) 0.95
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing. Histochemistry (1993) 0.94
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Am J Gastroenterol (2000) 0.94
[Non ossifying fibroma with vertebral localization. Clinical case]. Riv Neurol (1989) 0.94